Liposomal Enzyme Nanoreactors Based on Nanoconfinement for Efficient Antitumor Therapy

Angew Chem Int Ed Engl. 2023 Oct 26;62(44):e202308761. doi: 10.1002/anie.202308761. Epub 2023 Sep 25.

Abstract

Enzymatic reactions can consume endogenous nutrients of tumors and produce cytotoxic species and are therefore promising tools for treating malignant tumors. Inspired by nature where enzymes are compartmentalized in membranes to achieve high reaction efficiency and separate biological processes with the environment, we develop liposomal nanoreactors that can perform enzymatic cascade reactions in the aqueous nanoconfinement of liposomes. The nanoreactors effectively inhibited tumor growth in vivo by consuming tumor nutrients (glucose and oxygen) and producing highly cytotoxic hydroxyl radicals (⋅OH). Co-compartmentalization of glucose oxidase (GOx) and horseradish peroxidase (HRP) in liposomes could increase local concentration of the intermediate product hydrogen peroxide (H2 O2 ) as well as the acidity due to the generation of gluconic acid by GOx. Both H2 O2 and acidity accelerate the second-step reaction by HRP, hence improving the overall efficiency of the cascade reaction. The biomimetic compartmentalization of enzymatic tandem reactions in biocompatible liposomes provides a promising direction for developing catalytic nanomedicines in antitumor therapy.

Keywords: Anticancer Therapy; Biomimetic Systems; Cascade Reactions; Catalytic Nanomedicines; Liposomes.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Glucose Oxidase / pharmacology
  • Horseradish Peroxidase
  • Humans
  • Hydrogen Peroxide / therapeutic use
  • Liposomes
  • Nanotechnology
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology

Substances

  • Liposomes
  • Antineoplastic Agents
  • Glucose Oxidase
  • Horseradish Peroxidase
  • Hydrogen Peroxide